Smith Mary L.
SEC insider (Form 3/4/5 filer). CIK 0001866044. Director at PTC THERAPEUTICS, INC. (PTCT). 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 9, 2026. Located in WARREN, NJ.
Companies Smith Mary L. has filed insider reports for
- PTC THERAPEUTICS, INC. (PTCT): Director
Smith Mary L.
CIK: 0001866044
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (33.3%)
Position reduction
Option Exercises (M)2 (33.3%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PTCT
PTC THERAPEUTICS, INC.
Director
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 9, 2026PTCT
PTC THERAPEUTICS, INC.
ExerciseDirect10K shares at avg. $42.95$430K - Jul 9, 2026PTCT
PTC THERAPEUTICS, INC.
SaleDirect10K shares at avg. $90.00$900K - Jul 9, 2026PTCT
PTC THERAPEUTICS, INC.
ExerciseDirect5.8K shares at avg. $42.95$251K - Jul 9, 2026PTCT
PTC THERAPEUTICS, INC.
SaleDirect5.8K shares at avg. $90.00$525K - Jan 2, 2026PTCT
PTC THERAPEUTICS, INC.
AwardDirect4K shares- - Jan 3, 2025PTCT
PTC THERAPEUTICS, INC.
AwardDirect4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 9, 2026 | PTCT PTC THERAPEUTICS, INC. | Exercise | 10,000 | $42.95 | $429,500 | Direct |
| Jul 9, 2026 | PTCT PTC THERAPEUTICS, INC. | Sale | 10,000 | $90.00 | $900,000 | Direct |
| Jul 9, 2026 | PTCT PTC THERAPEUTICS, INC. | Exercise | 5,834 | $42.95 | $250,570 | Direct |
| Jul 9, 2026 | PTCT PTC THERAPEUTICS, INC. | Sale | 5,834 | $90.00 | $525,060 | Direct |
| Jan 2, 2026 | PTCT PTC THERAPEUTICS, INC. | Award | 4,000 | - | $0 | Direct |
| Jan 3, 2025 | PTCT PTC THERAPEUTICS, INC. | Award | 4,000 | - | $0 | Direct |
1-6 of 6 transactions